HIDA scans are considered very safe. The radioactive tracer used delivers a low radiation dose, adverse reactions to the pharmaceutical itself are rare and usually mild, and the procedure carries no pain beyond the needle stick of an IV line. That does not mean the scan is completely without risk or discomfort, though. The tracer, the supplemental drugs sometimes given during the exam, and the small radiation exposure each deserve a closer look, especially for people who are pregnant, very young, or managing other health conditions.
What Happens During a HIDA Scan
A HIDA scan (formally called hepatobiliary iminodiacetic acid scintigraphy, or cholescintigraphy) is a nuclear medicine imaging test. A technologist injects a small amount of a radioactive tracer, typically a technetium-99m-labeled compound, into a vein in your arm. The tracer travels through the bloodstream to the liver, which picks it up and excretes it into the bile ducts and gallbladder, mimicking the path bile normally takes.1British Journal of Surgery. An evaluation of 99Tcm-labelled HIDA in hepatobiliary scanning A gamma camera positioned over your abdomen records images as the tracer moves through the system, usually over about an hour. If the gallbladder fills normally and empties on cue, the scan is reassuring. If the tracer never reaches the gallbladder, or if the gallbladder empties sluggishly, those patterns help diagnose problems like acute cholecystitis or biliary dyskinesia.
The scan itself is passive from your perspective. You lie on a table while the camera does its work. There is no contrast dye injected into a duct, no scope inserted, and no sedation required. That simplicity is part of why the safety profile is favorable compared with more invasive diagnostic procedures.
The Radiation Dose in Perspective
The tracer is radioactive, so you do receive a measurable radiation dose. A typical adult HIDA scan delivers roughly 2 to 4 millisieverts (mSv) of effective dose, depending on the specific compound and the amount injected. For context, the average person in the United States absorbs about 3 mSv per year just from natural background sources like radon, cosmic rays, and trace radioactivity in food and soil. A single HIDA scan, then, adds roughly the equivalent of one extra year of everyday background exposure.
That puts the HIDA scan at the lower end of medical imaging doses. A standard chest CT delivers around 7 mSv, and an abdominal CT can reach 8 to 10 mSv or more. A plain chest X-ray is far lower, around 0.02 mSv, so a HIDA scan is not trivial by comparison, but it sits well below the dose range of most CT exams.
The long-standing model used for radiation protection assumes that any dose, no matter how small, carries some theoretical increase in cancer risk, with no safe threshold. This “linear no-threshold” model is used for regulatory purposes, but the actual evidence at the low doses involved in diagnostic imaging is murky. Studies of atomic bomb survivors show a clear excess cancer risk at high doses, and children exposed at young ages carry a higher risk than adults exposed to the same dose.2The Lancet. Japan: from Hiroshima and Nagasaki to Fukushima Whether the tiny doses from a single diagnostic scan translate into a detectable real-world cancer risk remains debated. Most radiation safety experts treat the risk as real but extremely small for any one scan, and they weigh it against the clinical benefit of getting a timely, accurate diagnosis.
Side Effects from the Tracer
Adverse reactions to the radiopharmaceutical injected during a HIDA scan are uncommon and, when they occur, tend to be mild. A review of adverse reactions to liver-imaging radiopharmaceuticals found that nausea, vomiting, skin flushing, rash, itching, and hives are among the reactions that have been reported.3Nuclear Medicine Communications. Adverse reactions to radiopharmaceuticals: liver radiopharmaceuticals Respiratory symptoms and fever have also been documented, though less frequently. The reason these reactions are rare is straightforward: the amount of pharmaceutical in a radiopharmaceutical dose is tiny compared with a therapeutic drug. You are receiving micrograms of material, not milligrams.
The same review notes that the pharmaceutical component of the tracer, not the radiation, is the main trigger for the rare reactions that do happen.3Nuclear Medicine Communications. Adverse reactions to radiopharmaceuticals: liver radiopharmaceuticals In extremely rare cases, severe allergic reactions including shock have been reported, and there are isolated reported cases of death, though the literature makes clear these are extraordinary outliers across millions of administered doses. If you have ever had a reaction to a nuclear medicine tracer in the past, mention it to your care team before the scan.
Medications Given During the Scan
A HIDA scan sometimes involves more than just the tracer. Depending on what your doctor needs to evaluate, you may receive an additional drug partway through the imaging session. These adjunct medications carry their own set of possible side effects, and for many patients, they are the source of more noticeable discomfort than the tracer itself.
Sincalide (CCK-8)
If the goal is to measure how well your gallbladder empties, also known as the ejection fraction, the technologist will infuse sincalide, a synthetic form of the hormone cholecystokinin. Sincalide causes the gallbladder to contract, simulating the effect of eating a fatty meal. The main side effects are nausea and abdominal cramping, and these are most likely to happen when the drug is infused too quickly.4Journal of Nuclear Medicine Technology. Sincalide: A Review of Clinical Utility, Proper Infusion Methodology, and Alternative Cholecystogogues A slower infusion rate, typically over 30 to 60 minutes, significantly reduces those symptoms. The only firm contraindications are a known allergy to sincalide, pregnancy, and intestinal obstruction.4Journal of Nuclear Medicine Technology. Sincalide: A Review of Clinical Utility, Proper Infusion Methodology, and Alternative Cholecystogogues
Morphine
When the scan is being done to diagnose acute cholecystitis and the gallbladder has not filled with tracer after about an hour, a small dose of morphine may be given intravenously. Morphine tightens the sphincter of Oddi, the muscular valve where the bile duct meets the small intestine, which redirects bile flow toward the gallbladder.5PubMed. The effects of morphine on biliary dynamics. A scintigraphic study with 99mTc-HIDA If the gallbladder still does not fill after an additional 30 minutes, the scan is considered positive for acute cholecystitis.6PubMed. Cholecystokinin and morphine pharmacological intervention during 99mTc-HIDA cholescintigraphy: a rational approach
The morphine dose used is small, but it is still an opioid, and it can cause nausea, lightheadedness, drowsiness, or a brief drop in blood pressure. These effects are generally mild and short-lived at the dose given during a HIDA scan. The more consequential issue with morphine is its potential to interfere with accuracy: opioids circulate for hours in the bloodstream and can suppress gallbladder contraction, artificially lowering the ejection fraction.6PubMed. Cholecystokinin and morphine pharmacological intervention during 99mTc-HIDA cholescintigraphy: a rational approach If you have been taking opioid pain medications before the scan, that information is critical for the interpreting physician to know, because it can change whether a low ejection fraction truly reflects gallbladder disease or is just a drug effect.
Common Discomforts That Are Not Really Side Effects
Many people report feeling uncomfortable during a HIDA scan, but most of the unpleasantness has nothing to do with the tracer or with radiation. The scan requires fasting, usually for four to six hours beforehand, which can leave you feeling hungry, shaky, or mildly headachy. The exam itself takes at least an hour and often longer, and you need to remain relatively still on a hard imaging table for that duration. Back pain, restlessness, and general boredom are frequently mentioned in patient forums, and they are worth knowing about, but they are not pharmacological side effects.
Occasionally the IV insertion causes a small bruise or brief stinging. If a tiny amount of tracer leaks into the tissue around the vein rather than entering the bloodstream, it can cause localized warmth or irritation at the injection site. This is a well-known nuisance in nuclear medicine, not a sign of a dangerous reaction, and it resolves on its own.
Pregnancy and Breastfeeding
Radiation exposure during pregnancy is a legitimate concern. The developing fetus is more sensitive to radiation than an adult, and the standard approach is to avoid any unnecessary radiation exposure during pregnancy. If you are pregnant and there is a strong clinical suspicion of gallbladder disease, ultrasound is the first-line tool because it involves no radiation at all. A HIDA scan during pregnancy would be reserved for situations where the clinical need is compelling enough to outweigh the radiation risk, and that decision would be made on a case-by-case basis by your medical team.
For breastfeeding, the concern is whether the radioactive tracer can pass into breast milk and be ingested by the infant. Technetium-99m compounds are excreted in small amounts in breast milk, and most guidelines recommend pumping and discarding milk for a period after the scan, commonly around 24 hours. Some nuclear medicine departments advise a shorter interruption depending on the specific tracer. Ask the imaging facility about their specific protocol before the scan so you can pump and store milk in advance if needed.
HIDA Scans in Children
Children receive HIDA scans less frequently than adults, but the procedure is used in pediatric cases, particularly for evaluating biliary atresia in newborns or gallbladder function in older children. Because children are smaller and their tissues are still developing, radiation dose management matters more. Pediatric dosing guidelines call for scaling the amount of injected tracer based on body weight, and there is active work to standardize those doses internationally. A study comparing dosing practices at a tertiary hospital in South Africa with North American and UK guidelines found considerable variability. The hospital’s doses for pediatric HIDA scans averaged about 13.7 MBq per kilogram, while the North American consensus guidelines recommended only 3.6 MBq per kilogram.7Current Radiopharmaceuticals. Administered Pediatric Radiopharmaceutical Doses at a Tertiary Hospital in South Africa: A Comparison with Corresponding Activities Based on North American Consensus Guidelines and Administration of Radioactive Substances Advisory Committee Guidelines That study recommended adopting the lower-dose guidelines, reinforcing the broader push in nuclear medicine to keep pediatric radiation as low as reasonably achievable.
The practical implication for parents is simple: pediatric nuclear medicine departments in major medical centers are generally well aware of these dose-optimization efforts. If your child is scheduled for a HIDA scan, it is entirely reasonable to ask whether the facility follows current weight-based dosing guidelines. The safety of the scan itself, in terms of side effects from the tracer, is comparable to that in adults. Adverse reactions remain rare.
When Other Conditions Affect the Scan
Certain medical conditions do not make a HIDA scan dangerous, but they can make it less useful, and that distinction matters. If you have significantly elevated bilirubin levels, the liver may not take up and excrete the tracer efficiently, which compromises image quality. Research has consistently shown that when total bilirubin exceeds roughly 5 mg/dL, the scan becomes less reliable. One study of patients after liver transplantation found that scans performed when bilirubin was below that threshold had high sensitivity and specificity for detecting biliary complications, but above 5 mg/dL, the rate of inconclusive or falsely negative results climbed substantially.8PubMed. Tc-99m-BrIDA hepatobiliary (HIDA) scan has a low sensitivity for detecting biliary complications after orthotopic liver transplantation in patients with hyperbilirubinemia Earlier research in jaundiced patients reached a similar conclusion, finding the scan diagnostically useful up to a bilirubin of about 5 mg/dL but of limited value beyond that point.9PubMed. Diagnosis of hepatobiliary disease by 99mTc-HIDA cholescintigraphy
This is not a safety issue in the sense that high bilirubin makes the scan harmful. It is a diagnostic quality issue: you absorb the radiation exposure either way, so if the scan is unlikely to produce a clear answer, your doctor may opt for a different imaging approach. That is a conversation worth having before the scan if you know your bilirubin is elevated.
For people with chronic kidney disease, the picture is less well studied. A systematic review of radiopharmaceutical use in patients with impaired kidney function found dose recommendations and guidance mainly for FDG, the tracer used in PET scans, and not specifically for HIDA agents.10PubMed Central. Safe use of radiopharmaceuticals in patients with chronic kidney disease: a systematic review Since the HIDA tracer is cleared primarily by the liver rather than the kidneys, kidney disease is less of a concern for this particular scan than it would be for a renal-cleared radiopharmaceutical. Still, reduced kidney function could affect how long trace amounts of the compound circulate in the body, and if you have advanced kidney disease, your nuclear medicine team should be aware of it.
How HIDA Compares to Ultrasound and Other Options
Ultrasound is the usual first test when gallbladder problems are suspected. It is fast, cheap, widely available, involves no radiation, and excels at finding gallstones. Its specificity for acute acalculous cholecystitis, the type without visible stones, is high, reported between 93% and 97% in one evidence review, but its sensitivity varies widely, from as low as 20% to as high as 100% depending on the study.11Insights into Imaging. What imaging modalities should be considered in suspected acute acalculous cholecystitis? A review of the evidence HIDA scans showed similar variability in sensitivity (38% to 100%) but with specificity ranging from 78% to 100%.11Insights into Imaging. What imaging modalities should be considered in suspected acute acalculous cholecystitis? A review of the evidence
The takeaway is not that one test is universally better than the other. Each answers a slightly different question. Ultrasound is excellent for anatomy: is there a stone blocking the duct, is the gallbladder wall thickened, is there fluid around it? A HIDA scan is better at function: is bile actually flowing through the system, and is the gallbladder contracting properly? In practice, an ultrasound is usually done first, and a HIDA scan is ordered when the ultrasound does not provide a clear answer or when functional information is needed, such as measuring the ejection fraction. From a safety standpoint, the trade-off is straightforward: ultrasound has zero radiation risk, while a HIDA scan adds a small radiation dose but can answer clinical questions ultrasound cannot.
CT and MRI are also used for biliary imaging, though evidence for their superiority over ultrasound in diagnosing acalculous cholecystitis is limited.11Insights into Imaging. What imaging modalities should be considered in suspected acute acalculous cholecystitis? A review of the evidence CT involves higher radiation doses than a HIDA scan. MRI avoids radiation entirely, like ultrasound, but is more expensive, slower, and less available, which limits its role in acute settings. Your doctor’s choice of test will depend on the specific clinical question, not on a blanket ranking of imaging safety.
Morphine-Augmented Scans and Diagnostic Accuracy
Some patients understandably feel uneasy about receiving morphine during a diagnostic test. The protocol exists because it shortens the exam and improves diagnostic clarity. Without morphine augmentation, a HIDA scan that fails to show gallbladder filling after one hour would traditionally require delayed imaging, sometimes up to four hours later, to confirm whether the gallbladder truly cannot fill. The morphine-augmented approach compresses that timeline to about 90 minutes total.
A study comparing morphine-augmented HIDA protocols found that accuracy reached about 95%, with sensitivity of 93% and specificity of 95%.12Europe PMC / American Journal of Roentgenology. Morphine-Modified Hepatobiliary Scanning Protocol for the Diagnosis of Acute Cholecystitis That high specificity is particularly useful because it means a positive result strongly suggests real disease rather than a false alarm, which helps avoid unnecessary surgery. If morphine is part of your scan protocol, the dose is small and the side effects are typically limited to transient nausea or mild drowsiness. You should not need to drive immediately afterward, and your facility will advise you on how long to wait.
Opioid Use and False Results
One practical concern that does not get enough attention is how prior opioid use, whether from a prescription painkiller or recreational use, can skew HIDA scan results. Opioids tighten the sphincter of Oddi, the same mechanism deliberately exploited when morphine is given during the scan. If you have been taking opioid medications in the hours or days before a HIDA scan, your gallbladder ejection fraction may read as abnormally low even if the gallbladder is functioning normally.6PubMed. Cholecystokinin and morphine pharmacological intervention during 99mTc-HIDA cholescintigraphy: a rational approach
This matters because a falsely low ejection fraction can lead to a diagnosis of biliary dyskinesia and, in some cases, to a cholecystectomy (gallbladder removal) that may not have been necessary. If you are taking opioids for chronic pain or have used them recently, make sure the ordering physician and the nuclear medicine team know. In some cases, they may ask you to stop opioids for a period before the scan, or they will interpret the ejection fraction result with that context in mind. This is not a safety risk of the scan per se, but it is a real-world risk of getting an inaccurate result, which can carry consequences of its own.
Repeat Scans and Cumulative Exposure
Most people undergo a HIDA scan once or twice in their lives, and the cumulative radiation from that is negligible in terms of long-term risk. But some patients with complex biliary problems, post-surgical complications, or chronic conditions may need multiple scans over time. Each scan adds another 2 to 4 mSv, and while any single dose is small, the question of cumulative exposure is reasonable.
The practical answer is that nuclear medicine professionals apply the ALARA principle: as low as reasonably achievable. Every scan should have a clear clinical justification, and if an alternative test (like an ultrasound or an MRI of the biliary tree) can answer the question without additional radiation, that option should be considered first. If you have had multiple imaging studies involving radiation, whether HIDA scans, CT scans, or other nuclear medicine exams, keeping a rough personal record of those exposures is a sensible habit. It helps your doctors weigh the incremental benefit of each additional scan against the small but real cumulative dose.
For the large majority of patients, a single HIDA scan is a low-risk, well-tolerated procedure that provides diagnostic information difficult to obtain any other way. The radiation is modest, the tracer reactions are uncommon and mild, and the adjunct medications, while occasionally uncomfortable, are generally well managed with proper technique. The most realistic risks are not from the scan itself but from the downstream decisions it informs, which is why accurate patient history, particularly regarding opioid use, fasting compliance, and bilirubin levels, matters as much as the imaging technology.